Shantel Zwissler
Psychiatric/Mental Health · Cincinnati, OHNPI 1538791983
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.9% of the total across 332 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 21 manufacturers, the largest accounting for just 17.1% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $2,416, 5.5 times the $442 reported in 2021. Among psychiatric/mental health clinicians in OH with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 332 payments — averaging $18.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Otsuka America Pharmaceutical, Inc.$1K
- AbbVie$810
- Supernus Pharmaceuticals, Inc.$741
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$563
- Alkermes, Inc.$480
- Lundbeck LLC$467
- plus $2K from 15 others
What the payments were for
- Food & beverage$6,282100%
- Education$70%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 52 | $1,073 |
| AbbVie | 59 | $810 |
| Supernus Pharmaceuticals, Inc. | 43 | $741 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 24 | $563 |
| Alkermes, Inc. | 22 | $480 |
| Lundbeck LLC | 23 | $467 |
| Johnson & Johnson | 13 | $395 |
| Teva Pharmaceuticals USA, Inc. | 12 | $269 |
| Ironshore Pharmaceuticals Inc. | 18 | $252 |
| Corium, LLC | 11 | $229 |
| Noven Therapeutics, LLC | 15 | $226 |
| Axsome Therapeutics, Inc. | 6 | $158 |
| Neurocrine Biosciences, Inc. | 7 | $140 |
| Indivior Inc. | 7 | $128 |
| Tris Pharma Inc | 6 | $96 |
| Collegium Pharmaceutical, Inc. | 5 | $87 |
| Vanda Pharmaceuticals Inc. | 3 | $82 |
| Luye Pharma (USA) Ltd. | 2 | $30 |
| Vertical Pharmaceuticals, LLC | 2 | $28 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $25 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ABILIFY ASIMTUFII$246
- ABILIFY MAINTENA$246
- INVEGA SUSTENNA$125
- QELBREE$123
How this compares
$6,288 in reported general payments places this provider in the 90th percentile of 1,808 psychiatric/mental health providers in Ohio.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Aripiprazole | 16 | $770 |
| Clonazepam | 30 | $517 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 13 | $332 |
| Buspirone Hcl | 22 | $285 |
| Prazosin Hcl | 12 | $284 |
| Hydroxyzine Pamoate | 11 | $210 |
| Mirtazapine | 14 | $168 |
| Escitalopram Oxalate | 27 | $141 |
| Benztropine Mesylate | 11 | $131 |
| Alprazolam | 15 | $87 |
Paid to pharmacies, not to this prescriber.
Other psychiatric/mental health in Cincinnati
- Michelle McBrideCincinnati$29K
- Seth FramptonCincinnati$10K
- Crystal TravisJackson$333K
- Kristina RoweIronton$253K
- Patricia SparksPortsmouth$210K
- Mary HallWarren$195K
- Kassandra KornbauCanfield$170K
- Steven MatesDayton$121K
- Robert ParsonsYoungstown$119K
- Chriscia BaneChillicothe$115K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.